[1,8] naphthyridine derivatives having antiviral activity
US6605614B2 · kind B2 · utility
26Cited by
1References
49Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 27, 2001 |
| Grant date | Aug 12, 2003 |
| Priority date | — |
| Expiry date | Dec 27, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is concerned with novel [1,8] naphthyridine derivatives useful for the inhibition of the hepatitis virus, more specifically the hepatitis C virus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.